31602-63-8

Basic information

• Product Name: C-(2H-TETRAZOL-5-YL)-METHYLAMINE
• Synonyms: C-(2H-TETRAZOL-5-YL)-METHYLAMINE;1H-tetrazol-5-ylmethylamine;(1H-tetrazol-5-ylmethyl)amine(SALTDATA: FREE);1H-1,2,3,4-tetrazol-5-ylMethanaMine;1H-Tetrazole-5-MethanaMine;2H-Tetrazole-5-MethanaMine;(1H-Tetrazol-5-yl)methanamine;[(2H-Tetrazol-5-yl)methyl]amine
• CAS NO: 31602-63-8
• Molecular Formula: C₂H₅N₅
• Molecular Weight: 99.09
• EINECS: 604-604-1
• Product Categories: Heterocycles series
• Mol File: 31602-63-8.mol
• Article Data: 4

Chemical Properties

• Melting Point: 265°C
• Boiling Point: 316.451 °C at 760 mmHg
• Flash Point: 171.024 °C
• Appearance: /
• Density: 1.469
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.611
• PKA: 2.94±0.10(Predicted)
• CAS DataBase Reference: C-(2H-TETRAZOL-5-YL)-METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: C-(2H-TETRAZOL-5-YL)-METHYLAMINE(31602-63-8)
• EPA Substance Registry System: C-(2H-TETRAZOL-5-YL)-METHYLAMINE(31602-63-8)

Safety Data

• Hazardous Substances Data: 31602-63-8(Hazardous Substances Data)

Usage

General Description

C-(2H-tetrazol-5-yl)-methylamine, also known as C-Tetra, is a chemical compound with the molecular formula C3H7N5. It is a white crystalline powder that is commonly used as a building block in organic synthesis and pharmaceutical research. C-Tetra has been studied for its potential as a central nervous system stimulant and has also been investigated for its antibiotic and antiparasitic properties. C-(2H-TETRAZOL-5-YL)-METHYLAMINE is known for its stability and relatively low toxicity, making it a valuable tool for drug discovery and medicinal chemistry. However, it should be handled and stored with care, as it can be hazardous if not used properly.

InChI:InChI=1/C2H5N5/c3-1-2-4-6-7-5-2/h1,3H2,(H,4,5,6,7)

Upstream product

• 108723-22-4 N-(1H-tetrazol-5-ylmethyl)-acetamide 
• 118764-13-9 1H-1,2,3,4-tetrazol-5-ylmethanamine hydrochloride 
• 55408-11-2 5-chloromethyl-1H-tetrazole 
• 107269-64-7 C-(1-benzyl-1H-tetrazol-5-yl)-methylamine; hydrochloride 
• 114841-44-0 2-((1H-tetrazol-5-yl)methyl)isoindoline-1,3-dione 

Downstream Products

• 141330-42-9 N-(4-Cyano-phenyl)-N',N''-dicyclooctyl-guanidine 
• 141330-43-0 N-(4-Cyano-phenyl)-N',N''-bis-(1H-tetrazol-5-ylmethyl)-guanidine 
• 120510-68-1 N-(4-cyanophenyl)-N'-cyclooctyl-N''-(1H-tetrazol-5-ylmethyl)guanidine 
• 130816-14-7 N-cyanophenyl-N'-5-tetrazolylmethyl thiourea 
• 130816-13-6 N-cyanophenyl-N'-5-tetrazolylmethyl urea 
• 342612-74-2 Pyrazine-2-carboxylic acid ((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-1-{hydroxy-[(1H-tetrazol-5-ylmethyl)-carbamoyl]-methyl}-propylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butyl)-amide 
• 863253-31-0 Pyrazine-2-carboxylic acid ((S)-1-{(1S,2S)-1-[(S)-2-cyclohexyl-1-((S)-3,3-difluoro-1-{hydroxy-[(1H-tetrazol-5-ylmethyl)-carbamoyl]-methyl}-propylcarbamoyl)-ethylcarbamoyl]-2-methyl-butylcarbamoyl}-3-methyl-butyl)-amide 
• 1469858-84-1 (2S)-2-({[(4-bromophenyl)amino]carbonyl}amino)-4-methyl-N-(1H-tetrazol-5-ylmethyl)pentanamide 

Relevant articles and documents

Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA)

A known side-activity of the oral potassium-sparing diuretic drug amiloride is inhibition of the enzyme urokinase-type plasminogen activator (uPA, K i = 7 μM), a promising anticancer target. Several studies have demonstrated significant antitum

Synthesis of tetrazole analogues of amino acids using Fmoc chemistry: isolation of amino free tetrazoles and their incorporation into peptides

An efficient synthesis of tetrazole analogues of amino acids starting from Nα-Fmoc amino acid in a three-step protocol is reported. The free amino tetrazoles were obtained in good yields and with excellent purity after removal of the Fmoc group